Home › Funds › Kera Capital Partners, Inc. › BBC
Kera Capital Partners, Inc. position in BBC
VIRTUS LIFESCI BIOTECH CLINICAL TRIALS ETF
Kera Capital Partners, Inc. reported holding 101,003 shares of BBC (VIRTUS LIFESCI BIOTECH CLINICAL TRIALS ETF) in its Q2 2026 13F filing — a position valued at US$5.3M, representing 0.54% of its reported portfolio and ranking #39 among its reported holdings. Kera Capital Partners, Inc. has disclosed BBC holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Kera Capital Partners, Inc.'s BBC position evolved
Kera Capital Partners, Inc. first disclosed a stake in BBC in Q4 2025 at 84,970 shares (US$3.5M). The position peaked in Q2 2026 at 101,003 shares, worth US$5.3M. Across 3 filings, Kera Capital Partners, Inc. increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 101,003 shares valued at US$5.3M — an increase of 11,639 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 84.97K | $3.47M | New |
| Q1 2026 | 89.36K | $3.72M | Add |
| Q2 2026 | 101.00K | $5.32M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BBC and 13F data
BBC (VIRTUS LIFESCI BIOTECH CLINICAL TRIALS ETF) is a company whose sector is not yet classified in our data. 20 other funds we track also report a position in BBC. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on Kera Capital Partners, Inc.
FAQ
How long has Kera Capital Partners, Inc. held BBC?
Kera Capital Partners, Inc. has disclosed BBC holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Kera Capital Partners, Inc.'s current position in BBC?
As of Q2 2026, Kera Capital Partners, Inc. holds 101.00K shares of BBC (VIRTUS LIFESCI BIOTECH CLINICAL TRIALS ETF), valued at $5.32M, representing 0.54% of its reported portfolio and ranking #39.
Has Kera Capital Partners, Inc. been buying or selling BBC?
In the latest 13F filing (Q2 2026), Kera Capital Partners, Inc. increased its position in BBC. The position peaked in Q2 2026 at 101.00K shares.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.